Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene

Haematologica

Volumn 94, Issue 11, 2009, Pages 1627-1629

  Nurden, Paquita ^a   Nurden, Alan T ^a   La Marca, Silvia ^b   Punzo, Margherita ^b   Baronciani, Luciano ^b   Federici, Augusto B ^b  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Megakaryocytopoiesis; Platelets; Von willebrand disease

Indexed keywords

VON WILLEBRAND FACTOR;

CELL MATURATION; CELL MEMBRANE; CELL SIZE; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; GENE DELETION; HOMOZYGOSITY; HUMAN; LETTER; MEGAKARYOCYTE; THROMBOCYTE STRUCTURE; VON WILLEBRAND DISEASE;

BLOOD PLATELETS; HOMOZYGOTE; HUMANS; SEQUENCE DELETION; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 70449432760     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.012658     Document Type: Letter

References (12)

1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998;67:395-424. (Pubitemid 28411134)
2. Federici AB, Mannucci PM, Castaman G, Baronciani L, Bucciarelli P, Canciani MT, et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: A cohort study of 67 patients. Blood 2009;113:526-534
3. Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, Corvazier E, et al. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 2006;108:2587-2595 (Pubitemid 44776992)
4. Slayton WB, Patel M, Sola-Visner M, Harris N, Rivers A, Montgomery RR, et al. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow. J Pediatr Hematol Oncol 2008;30:708-711
5. Jackson SC, Sinclair GD, Cloutier S, Duan Z, Rand ML, Poon MC. The Montreal platelet syndrome kindred have type 2B von Willebrand disease with the VWF 1316 mutation. Blood 2009;113:3348-3351
6. Shelton-Inloes BB, Chehab FF, Mannucci PM, Federici AB, Sadler JE. Gene deletions correlate with the development of alloantibodies in von Willebrand disease. J Clin Invest 1987;79:1459-1465
7. Schneppenheim R, Castaman G, Federici AB, Kreuz W, Marschalek R, Oldenburg J, et al. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3. J Thromb Haemost 2007;5:722-728 (Pubitemid 46563570)
8. Balduini A, Pallotta I, Malara A, Lova P, Pecci A, Viarengo G, et al. Adhesive receptors, extracellular proteins, and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J Thromb Haemost 2008;6:1900-1907
9. Poujol C, Ware J, Nieswandt B, Nurden AT, Nurden P. Absence of GPIbα is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Exp Hematol 2002;30:352-360 (Pubitemid 34286441)
10. Nurden P, Chretien F, Poujol C, Winckler J, Borel-Derlon A, Nurden A. Platelet ultrastructural abnormalities in three patients with type 2B von Willebrand disease. Br J Haematol 2000;110:704-714 (Pubitemid 30769273)
11. Villeneuve J, Block A, Le Bousse-Kerdilès MC, Lepreux S, Nurden P, Ripoche J, et al. Tissue inhibitors of matrix metalloproteases in platelets and megakaryocytes: a novel organization for these secreted proteins. Exp Hematol 2009;37:849-856
12. Pifferi S, Dibattista M, Menini A. TMEM16B induces chloride currents activated by calcium in mammalian cells. Pflugers Arch 2009;458:1023-1038